CC BY-NC-ND 4.0 · Journal of Child Science 2017; 07(01): e1-e3
DOI: 10.1055/s-0037-1603743
Case Report
Georg Thieme Verlag KG Stuttgart · New York

A Novel Mutation in the AVPR2 Gene in a Palestinian Family with Nephrogenic Diabetes Insipidus

Abdulsalam Abu-Libdeh
1   Department of Pediatrics, Makassed Islamic Hospital, Jerusalem, Israel
,
Isaiah D. Wexler
2   Department of Pediatrics, Hadassah University Hospital, Jerusalem, Israel
,
Imad Dweikat
1   Department of Pediatrics, Makassed Islamic Hospital, Jerusalem, Israel
,
David Zangen
2   Department of Pediatrics, Hadassah University Hospital, Jerusalem, Israel
,
Bassam Abu-Libdeh
1   Department of Pediatrics, Makassed Islamic Hospital, Jerusalem, Israel
› Institutsangaben
Weitere Informationen

Publikationsverlauf

26. März 2017

29. April 2017

Publikationsdatum:
21. Juni 2017 (online)

Abstract

Nephrogenic diabetes insipidus (NDI) is a urinary concentrating defect resulting from resistance of the collecting duct to the antidiuretic action of vasopressin (AVP). The X-linked recessive form is the most frequent genetic cause of inherited NDI and can be caused by mutations in the gene encoding the V2 vasopressin receptor (AVPR2). A Palestinian male infant presented in the neonatal period with failure to thrive, vomiting, irritability, fever, and polyuria, and had biochemical findings consistent with NDI. The diagnosis of NDI was established based on the clinical picture, absent response to desmopressin, and a similarly affected elder brother. Sequencing of the AVPR2 gene for the patient and his affected brother revealed a novel missense mutation with replacement of G by A in codon 82 located in exon 2 (TGC → TAC), causing a cysteine to tyrosine substitution (C82Y). Testing of the mother showed that she was the carrier of that mutation. This is the identified AVPR2 mutation in a Palestinian family. Knowledge of these mutations will allow genetic counseling and early diagnosis of affected males.

 
  • References

  • 1 van den Ouweland AM, Dreesen JC, Verdijk M. , et al. Mutations in the vasopressin type 2 receptor gene (AVPR2) associated with nephrogenic diabetes insipidus. Nat Genet 1992; 2 (02) 99-102
  • 2 Rosenthal W, Seibold A, Antaramian A. , et al. Molecular identification of the gene responsible for congenital nephrogenic diabetes insipidus. Nature 1992; 359 (6392): 233-235
  • 3 Morello JP, Bichet DG. Nephrogenic diabetes insipidus. Annu Rev Physiol 2001; 63: 607-630
  • 4 Arthus MF, Lonergan M, Crumley MJ. , et al. Report of 33 novel AVPR2 mutations and analysis of 117 families with X-linked nephrogenic diabetes insipidus. J Am Soc Nephrol 2000; 11 (06) 1044-1054
  • 5 Fujiwara TM, Morgan K, Bichet DG. Molecular biology of diabetes insipidus. Annu Rev Med 1995; 46: 331-343
  • 6 Stenson PD, Ball EV, Mort M. , et al. Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 2003; 21 (06) 577-581
  • 7 Birnbaumer M, Seibold A, Gilbert S. , et al. Molecular cloning of the receptor for human antidiuretic hormone. Nature 1992; 357 (6376): 333-335
  • 8 Spanakis E, Milord E, Gragnoli C. AVPR2 variants and mutations in nephrogenic diabetes insipidus: review and missense mutation significance. J Cell Physiol 2008; 217 (03) 605-617
  • 9 Wess J. G-protein-coupled receptors: molecular mechanisms involved in receptor activation and selectivity of G-protein recognition. FASEB J 1997; 11 (05) 346-354
  • 10 Albertazzi E, Zanchetta D, Barbier P. , et al. Nephrogenic diabetes insipidus: functional analysis of new AVPR2 mutations identified in Italian families. J Am Soc Nephrol 2000; 11 (06) 1033-1043